Twist Bioscience (TWST) Enterprise Value (2018 - 2026)

Twist Bioscience (TWST) has reported Enterprise Value for 9 consecutive years, with $6.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 219.98% year-over-year to $6.3 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 219.98% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 38.17% from the prior year.
• Enterprise Value was $6.3 billion for Q2 2026 at Twist Bioscience, up from $2.8 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $6.3 billion in Q2 2026 and troughed at $473.5 million in Q1 2023.
• A 5-year average of $2.0 billion and a median of $1.8 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value tumbled 78.51% in 2023 and jumped 259.5% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $910.0 million in 2022, then soared by 99.84% to $1.8 billion in 2023, then surged by 37.36% to $2.5 billion in 2024, then plunged by 30.12% to $1.7 billion in 2025, then jumped by 259.82% to $6.3 billion in 2026.
• The last three Enterprise Value figures came in at $6.3 billion (Q2 2026), $2.8 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.